---
$id: https://graph.org.ai/products/commodity/51142524
$type: Product
source: UNSPSC
code: "51142524"
title: "Doreptide"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Doreptide

**UNSPSC Code**: 51142524
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 51K3U6Q5ZN. European Medicines Agency schedules Doreptide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06371MIG. Doreptide generally arises in the molecular formula C17H24N4O3. The term DOREPTIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, no. 3, 1988, list 28.) DOREPTIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doreptide under HS 29339990 and SITC 51577. As of Q4 2014, DOREPTIDE remains the US FDA Preferred Term for this commodity. Doreptide bears US NLM identifiers UMLS ID C2699803 and NCI Concept Code C76393. SMILES: O=C(NC(CC)(C1CCCCC1)C(=O)NCC(=O)N)C1NCCC1.

